KEVIN LEWIS: Open Payments
NPI 1033312426 · DRIPPING SPRINGS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 75 payments from 26 companies in 2025. Trend: 2023 $2,073 · 2024 $1,641 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $178 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $169 |
| AstraZeneca Pharmaceuticals LP | 6 | $162 |
| PFIZER INC. | 4 | $76 |
| Amgen Inc. | 4 | $72 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Radius Health, Inc. | 3 | $63 |
| Novo Nordisk Inc | 3 | $61 |
| Lundbeck LLC | 2 | $60 |
| Lilly USA, LLC | 3 | $57 |
Products named: JARDIANCE, TRELEGY ELLIPTA, AIRSUPRA, REXULTI, BREZTRI, SPRAVATO, Tymlos, EVKEEZA.
Industry payments across TX — which companies pay providers there.
